AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol

Endocrinology

Volumn 153, Issue 5, 2012, Pages 2130-2141

  Habegger, Kirk M ^a,b,c   Hoffman, Nolan J ^a,b,c   Ridenour, Colin M ^a   Brozinick, Joseph T ^e   Elmendorf, Jeffrey S ^a,b,c,d  

^a INDIANA UNIVERSITY   (United States)

^b Centers for Diabetes Research   (United States)

^c Membrane Biosciences   (United States)

^d Vascular Biology and Medicine   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CHOLESTEROL; F ACTIN; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MYC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL SURFACE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; FEMALE; GENE SILENCING; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; SKELETAL MUSCLE; ZUCKER RAT;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CELL MEMBRANE; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE FIBERS, SKELETAL; RATS; RATS, ZUCKER; RIBONUCLEOTIDES;

EID: 84860339683     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2099     Document Type: Article

References (47)

1. Witczak CA, Sharoff CG, Goodyear LJ 2008 AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65: 3737-3755
2. Hoffman NJ, Elmendorf JS 2011 Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis. Trends Endocri-nol Metab 22:110-116
3. Jessen N, An D, Lihn AS, Nygren J, Hirshman MF, Thorell A, Goodyear LJ 2011 Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301:E164-E171
4. Taylor EB, An D, Kramer HF, Yu H, Fujii NL, Roeckl KS, Bowles N, Hirshman MF, Xie J, Feener EP, Goodyear LJ 2008 Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 283:9787-9796
5. Treebak JT, Taylor EB, Witczak CA, An D, Toyoda T, Koh HJ, Xie J, Feener EP, Wojtaszewski JF, Hirshman MF, Goodyear LJ 2010 Identification of a novel phosphorylation site on TBC1D4 regulated by AMP-activated protein kinase in skeletal muscle. Am J Physiol Cell Physiol 298:C377-C385
6. Qatanani M, Lazar MA 2007 Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21:1443-1455 (Pubitemid 46955717)
7. Habegger KM, Penque BA, Sealls W, Tackett L, Bell LN, Blue EK, Gallagher PJ, Sturek M, Alloosh MA, Steinberg HO, Considine RV, Elmendorf JS 2012 Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle. Diabetologia 55:457-467
8. Liu P, Leffler BJ, Weeks LK, Chen G, Bouchard CM, Strawbridge AB, Elmendorf JS 2004 Sphingomyelinase activates GLUT4 translocation via a cholesterol-dependent mechanism. Am J Physiol Cell Physiol 286:C317-C329 (Pubitemid 38146355)
9. Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS 2006 Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 20:857-870
10. Pattar GR, Tackett L, Liu P, Elmendorf JS 2006 Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat Res 610:93-100 (Pubitemid 44486910)
11. Czech MP 1980 Insulin action and the regulation of hexose transport. Diabetes 29:399-409 (Pubitemid 11027543)
12. Pilch PF, Thompson PA, Czech MP 1980 Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci USA 77:915-918 (Pubitemid 10108405)
13. Muller S, Denet S, Candiloros H, Barrois R, Wiernsperger N, Donner M, Drouin P 1997 Action of metformin on erythrocyte membrane fluidity in vitro and in vivo. Eur J Pharmacol 337:103-110 (Pubitemid 27468867)
14. Wiernsperger NF 1999 Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes. Diabetes Metab 25:110-127 (Pubitemid 29344451)
15. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174 (Pubitemid 32995375)
16. Sealls W, Penque BA, Elmendorf JS 2011 Evidence that chromium modulates cellular cholesterol homeostasis and ABCA1 functionality impairedbyhyperinsulinemia-brief report. Arterioscler Thromb Vasc Biol 31:1139-1140
17. Thirunavukkarasu M, Penumathsa SV, Juhasz B, Zhan L, Cordis G, Altaf E, Bagchi M, Bagchi D, Maulik N 2006 Niacin-bound chromium enhances myocardial protection from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 291:H820-H826 (Pubitemid 44175090)
18. Zhao P, Wang J, Ma H, Xiao Y, He L, Tong C, Wang Z, Zheng Q, Dolence EK, Nair S, Ren J, Li J 2009 A newly synthetic chromium complex-Chromium (d-phenylalanine)(3) activates AMP-activated protein kinase and stimulates glucose transport. Biochem Pharmacol 77:1002-1010
19. Yang J, Maika S, Craddock L, King JA, Liu ZM 2008 Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun 370: 248-253
20. Tang JJ, Li JG, Qi W, Qiu WW, Li PS, Li BL, Song BL 2011 Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab 13:44-56
21. Bhonagiri P, Pattar GR, Habegger KM, McCarthy AM, Tackett L, Elmendorf JS 2011 Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance. Endocrinology 152:3373-3384
22. McCarthy AM, Spisak KO, Brozinick JT, Elmendorf JS 2006 Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport. Am J Physiol Cell Physiol 291:C860-C868 (Pubitemid 44771805)
23. Brozinick Jr JT, Hawkins ED, Strawbridge AB, Elmendorf JS 2004 Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeletoninglucose transporter 4 translocation in insulin-sensitive tissues. J Biol Chem 279:40699-40706 (Pubitemid 39287665)
24. Khayat ZA, Tsakiridis T, Ueyama A, Somwar R, Ebina Y, Klip A 1998 Rapid stimulation of glucose transport by mitochondrial uncoupling depends in part on cytosolic Ca2 + and cPKC. Am J Physiol 275:C1487-C1497
25. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG 1996 Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879-27887 (Pubitemid 26367365)
26. Kishi K, Muromoto N, Nakaya Y, Miyata I, Hagi A, Hayashi H, Ebina Y 1998 Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway [Erratum (1998) 47:1170]. Diabetes 47:550-558 (Pubitemid 28160444)
27. Wang Q, Khayat Z, Kishi K, Ebina Y, Klip A 1998 GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS Lett 427:193-197 (Pubitemid 28225056)
28. Fazakerley DJ, Holman GD, Marley A, James DE, Stockli J, Coster AC 2010 Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes. J Biol Chem 285:1653-1660
29. Chen G, Raman P, Bhonagiri P, Strawbridge AB, Pattar GR, Elmendorf JS 2004 Protective effect of phosphatidylinositol 4,5-bis-phosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin. J Biol Chem 279:39705-39709 (Pubitemid 39258239)
30. Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA 1985 Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357-364 (Pubitemid 15243464)
31. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J 1985 Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76:149-155 (Pubitemid 15240430)
32. Blot V, McGraw TE 2006 GLUT4 is internalized by a cholesterol-dependent nystatin-sensitive mechanism inhibited by insulin. EMBO J 25:5648-5658 (Pubitemid 44967749)
33. Stöckli J, Fazakerley DJ, Coster AC, Holman GD, James DE 2010 Muscling in on GLUT4 kinetics. Commun Integr Biol 3:260-262
34. Antonescu CN, Diaz M, Femia G, Planas JV, Klip A 2008 Clathrin-dependent and independent endocytosis of glucose transporter 4 (GLUT4) in myoblasts: regulation by mitochondrial uncoupling. Traffic 9:1173-1190 (Pubitemid 351916891)
35. Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY 2006 Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114:2655-2662 (Pubitemid 44967349)
36. Wong AK, Howie J, Petrie JR, Lang CC 2009 AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin Sci (Lond) 116:607-620
37. Mu J, Brozinick Jr JT, Valladares O, Bucan M, Birnbaum MJ 2001 A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7:1085-1094 (Pubitemid 32525754)
38. Fujii N, Jessen N, Goodyear LJ 2006 AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 291:E867-E877
39. Parton RG, Molero JC, Floetenmeyer M, Green KM, James DE 2002 Characterization of a distinct plasma membrane macrodo-main in differentiated adipocytes. J Biol Chem 277:46769-46778 (Pubitemid 35417680)
40. Kanzaki M, Pessin JE 2002 Caveolin-associated filamentous actin (Cav-actin) defines a novel F-actin structure in adipocytes. J Biol Chem 277:25867-25869 (Pubitemid 34967065)
41. Foti M, Porcheron G, Fournier M, Maeder C, Carpentier JL 2007 The neck of caveolae is a distinct plasma membrane subdomain that concentrates insulin receptors in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 104:1242-1247 (Pubitemid 46183989)
42. Fujita A, Cheng J, Fujimoto T 2010 Quantitative electron microscopy for the nanoscale analysis of membrane lipid distribution. Nat Protoc 5:661-669
43. Kwik J, Boyle S, Fooksman D, Margolis L, Sheetz MP, Edidin M 2003 Membrane cholesterol, lateral mobility, and the phosphati-dylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc Natl Acad Sci USA 100:13964-13969 (Pubitemid 37499174)
44. Xiong W, Jordens I, Gonzalez E, McGraw TE 2010 GLUT4 issorted to vesicles whose accumulation beneath and insertion into the plasma membrane are differentially regulated by insulin and selectively affected by insulin resistance. Mol Biol Cell 21:1375-1386
45. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE 2008 IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7:421-433 (Pubitemid 351598028)
46. Strawbridge AB, Elmendorf JS 2005 Phosphatidylinositol 4,5-bis-phosphate reverses endothelin-1-induced insulin resistance via an actin-dependent mechanism. Diabetes 54:1698-1705 (Pubitemid 40770760)
47. Hao M, Bogan JS 2009 Cholesterol regulates glucose-stimulated insulin secretion through phosphatidylinositol 4,5-bisphosphate. J Biol Chem 284:29489-29498